Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1
Closed 45
2020
Q3
$0 Sell
1
-5
-83% -$1.4K ﹤0.01% 397
2020
Q2
$2K Buy
+6
New +$1.8K ﹤0.01% 397
2018
Q2
Sell
-44
Closed -$12K 402
2018
Q1
$12K Hold
44
0.01% 378
2017
Q4
$14K Sell
44
-7
-14% -$2.25K 0.01% 378
2017
Q3
$16K Hold
51
0.01% 382
2017
Q2
$14K Sell
51
-13
-20% -$3.44K 0.01% 378
2017
Q1
$17K Hold
64
0.01% 380
2016
Q4
$18K Buy
64
+19
+42% +$5.63K 0.01% 366
2016
Q3
$14K Hold
45
0.01% 383
2016
Q2
$11K Sell
45
-41
-48% -$10.8K 0.01% 377
2016
Q1
$22K Hold
86
0.02% 362
2015
Q4
$26K Sell
86
-113
-57% -$32.5K 0.02% 345
2015
Q3
$58K Hold
199
0.04% 301
2015
Q2
$80K Buy
199
+161
+424% +$64.6K 0.05% 295
2015
Q1
$16K Hold
38
0.01% 388
2014
Q4
$13K Buy
38
+4
+12% +$1.29K 0.01% 376
2014
Q3
$11K Hold
34
0.01% 386
2014
Q2
$11K Sell
34
-7
-17% -$2.11K 0.01% 364
2014
Q1
$13K Hold
41
0.01% 358
2013
Q4
$11K Buy
41
+1
+3% +$259 0.01% 357
2013
Q3
$10K Hold
40
0.01% 365
2013
Q2
$9K Buy
+40
New +$8.55K 0.01% 353

Other funds holding BIIB

Alpha Windward's BIIB Position: Q4 2020 in Review

Alpha Windward sold out of Biogen (BIIB) in Q4 2020, closing a stake of 1 share.

Alpha Windward first reported a position in BIIB in Q2 2013 and held it in 22 quarters. The position peaked at $80K in Q2 2015. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Alpha Windward reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Alpha Windward sold 1 Biogen share in Q4 2020.
  • Alpha Windward first reported a position in Biogen in Q2 2013 and held it in 22 quarters.
  • Alpha Windward's Biogen position peaked at $80K in Q2 2015.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Alpha Windward's 13F filing for Q4 2020.